JNCCN 360

Editors:

James L. Mohler, MD

Sandy Srinivas, MD

Advertisement

Advertisement

Maha H.A. Hussain, MD, on Castration-Resistant Prostate Cancer: Future Directions for PARP Inhibitors

Nicholas D. James, PhD, MBBS, on Frequency of Imaging Studies in Patients Treated With Enzalutamide

Maha H.A. Hussain, MD, on Managing Nausea and Fatigue in Men Treated for Prostate Cancer

Recent

Cabazitaxel or Androgen Receptor–Targeted Therapies for Metastatic Prostate Cancer

Noninvasive Blood Test May Improve Accuracy in Detecting Prostate Cancer

In-House Specialty Pharmacy and Cost of Therapies for Prostate Cancer

ESMO 2019: CHEIRON Update on Enzalutamide Plus Docetaxel in Castration-Resistant Prostate Cancer

Published

Medical Literature

Study Explores Link Between Diet and Prostate Cancer Risk

Use of Complementary and Alternative Medicine in Patients With Prostate Cancer

Updated Results From SPARTAN Trial on Apalutamide in Prostate Cancer

Small Cell Carcinoma of the Prostate: Update on Patterns of Care

Ongoing

Beyond the Guidelines: Investigator Perspectives on Current Clinical Issues and Ongoing Research in the Systemic Treatment of Prostate Cancer

Cases From the Community: Clinical Investigators Provide Their Perspectives on the Use of Immune Checkpoint Inhibitors in the Management of Actual Patients With Genitourinary Cancers

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care – Prostate Cancer

Current Approaches to the Treatment of Metastatic Castration-Resistant Prostate Cancer

Available

Clinical Trials

University of Wisconsin Carbone Cancer Center

University of Nebraska

UC San Diego Health Moores Cancer Center

NCCN Resources

Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.